Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog
Launched by OHIO STATE UNIVERSITY · Aug 5, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at older adults who are experiencing early signs of memory problems, specifically those diagnosed with either subjective cognitive decline (SCD) or mild cognitive impairment (MCI). The goal is to learn more about how these conditions develop over time, especially in individuals from under-resourced communities. Participants will be recruited through a Tele-Cog clinic, which means they can take part in the study from home using virtual visits.
To be eligible, you need to be at least 50 years old, have concerns about your memory or thinking skills, and be able to understand and speak English. It's also important that you can give permission to join the study and have someone who can help share information about your daily activities and memory. This trial is not yet recruiting participants, so if you or someone you know is interested, keep an eye out for updates. Participants will help researchers gather important information that could lead to better understanding and support for those facing cognitive challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults ages 50 years and older
- • 2. Diagnosed with subjective cognitive concerns (SCD) or objective cognitive decline with mostly intact functioning (MCI diagnosis) as part of clinical work up
- • 3. Fluent in English
- • 4. Able to provide voluntary informed consent
- • 5. Willing and able to undergo all study procedures
- • 6. Able to delegate, if possible, a study partner to contribute information regarding daily activities and cognition
- Exclusion Criteria:
- • 1. Diagnosis of dementia at baseline.
- • 2. Inability to give informed consent.
- • 3. High risk of adverse emotional or behavioral reaction based on investigator's clinical evaluation (e.g., evidence of serious personality disorder, antisocial behavior, serious current stressors, lack of meaningful social support).
About Ohio State University
The Ohio State University (OSU) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a commitment to improving patient care and outcomes, OSU leverages its extensive resources, interdisciplinary collaboration, and expertise in diverse medical fields. The university fosters an environment of rigorous scientific inquiry, ensuring that clinical trials are conducted with the highest ethical standards and adherence to regulatory guidelines. Through its Clinical Trials Office, OSU aims to translate groundbreaking research into practical applications, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported